Does Dr. JULES ALJAMMAL have financial conflicts of interest?

Dr. JULES ALJAMMAL (M.D.) has received a total of $24,694 in pharmaceutical and medical device industry funding between 2021 and 2025. This includes $23,694 in personal promotional payouts (consulting, meals, travel) and $1,000 in clinical research grants. Financial ties do not automatically imply conflict of interest, but are disclosed under the Sunshine Act.

Which pharmaceutical companies pay Dr. JULES ALJAMMAL?

According to CMS Open Payments data, Dr. JULES ALJAMMAL received funding from CAMBRIDGE INTERVENTIONAL ($20,866), ABBVIE ($3,360), and IBSA PHARMA ($106).

Does Dr. JULES ALJAMMAL receive research grants or speaking fees?

Dr. JULES ALJAMMAL has received $23,694 in general promotional payments (such as consulting honoraria, meals, and speaking fees) and $1,000 in clinical research grants.

DR. JULES ALJAMMAL

M.D.Real-Time Hydrated

Specialty: Internal Medicine, Endocrinology, Diabetes & Metabolism

Practice Location: ISSAQUAH, WA 98027

NPI Number: 1083846018

LIFETIME INDUSTRY VALUE

$24,694

2021 – 2025 Cumulative

Conflict of Interest Analysis

Dr. ALJAMMAL is a verified Internal Medicine, Endocrinology, Diabetes & Metabolism practitioner based in ISSAQUAH, WA.

Between 2021 and 2025, Dr. ALJAMMAL had an overall industry promotional and research financial footprint of $24,694 as recorded in the federal CMS Open Payments database.

$23,694 was received in general payments, which include consultation fees, travel expenses, honoraria, and sponsored meals.
$1,000 was allocated to sponsored clinical trials and medical research activities.

Dr. ALJAMMAL's primary funding source is CAMBRIDGE INTERVENTIONAL, which accounts for $20,866 (representing 84.5% of overall industry footprint).

Data coverage: 2021 – 2025 · Source: CMS Open Payments · CMS publishes each year's data around June 30 of the following year.

Payout Trend Over Time

General Payments

Research Funding

Top Funding Entities

Pharmaceutical & Device Manufacturers making direct payments

CAMBRIDGE INTERVENTIONAL

Rank 1

$20,866

84.5%

ABBVIE

Rank 2

$3,360

13.6%

IBSA PHARMA

Rank 3

$106

0.4%

Itemized Transaction Archives

Direct live query to Socrata CMS Open Payments API (Bypasses local DB)

Year:

2025

Filter < $250

Click "Load Live Logs" to query the federal Open Payments registry directly.

Frequently Asked Questions

Answers compiled using federal transparency disclosure records under the Sunshine Act.